TLSA
Tiziana Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · GB
$1.01
−3.81%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
916.9%
Return on equity
-216.0%
Return on assets
1308.5%
Return on invested capital
0.00x
Asset turnover
-$13.4M
Cash from operations
$0.02
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026